Frank E. Thomas - 05 Jan 2022 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Reporting relationship: Director
Issuer ticker: SPRO
Reported as of: 05 Jan 2022
Net transaction value: +$19,992
SEC form: 4
Accepted by SEC: 07 Jan 2022, 16:09:20 UTC
Prior SEC filing: 18 Aug 2021
Next SEC filing: 04 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Tamara Joseph, Attorney-in-Fact for Frank E. Thomas

Key filing fact

Frank E. Thomas filed Form 4 for Spero Therapeutics, Inc. (SPRO) on 07 Jan 2022.

Key facts

This page summarizes Frank E. Thomas's Form 4 filing for Spero Therapeutics, Inc. (SPRO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Jan 2022, 16:09.

Change

Previous filing in this sequence was filed on 18 Aug 2021.
Current net transaction value: +$19,992.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SPRO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $19,992
Shares: +2,214
Change %
Price: $9.03
Shares after: 2,214
Date: 05 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,214
Exercise price: $13.19
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.

Footnote F2

This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $20,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.

SEC remarks

Exhibit 24.1 - Power of Attorney